Management

Stop Blaming Tuskegee, Critics Say. It’s Not an ‘Excuse’ for Current Medical Racism.

When it comes to vaccine hesitancy, it's mainly academics and officials who are preoccupied with the history of the Tuskegee medical experiments.

Workforce

GovExec Daily: The NIH Director Talks Pandemic and Workforce Morale

Dr. Francis Collins speaks to GovExec's Courtney Bublé about his agency's role in fighting COVID-19.

Management

Dr. Rachel Levine Makes Transgender History in Confirmation as Assistant Secretary of HHS

Levine is the first ever Senate-confirmed trans official in U.S. history, but she faced anti-trans sentiments on her road to the historic confirmation.

Management

Birx Joins Air-Cleaning Industry Amid Land Grab for Billions in Federal COVID Relief

Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for COVID-19 protection. Donald Trump’s former adviser lands with one that built its business, in part, on ozone-emitting technology.

Defense

One Year into the Pandemic, Defense Department Data Remains Incomplete

Outstanding questions include: why are civilians dying at higher rates than troops?

Workforce

Coronavirus Roundup: More Feds Are Eligible for Vaccines; Calls to Review FOIA During Pandemic 

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

Management

One Year In: How COVID-19's Toll Compares With Other Causes of Death

COVID-19 has become the country’s third-leading cause of death, and isn’t far behind cancer.

Management

NIH Director on the Coronavirus Response: ‘We're Not Done Yet Here in March of 2021’

Government Executive interviewed Dr. Francis Collins about vaccines, long-term COVID, structural racism in research, workforce morale and more.

Workforce

Coronavirus Roundup: Watchdogs Suggest Improvements for IRS and OSHA’s Pandemic Operations

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

Workforce

When Your Chance for a COVID-19 Shot Comes, Don’t Worry About the Numbers

The Johnson & Johnson vaccine that the FDA cleared Saturday was 66% effective overall in preventing moderate to severe covid, while the Pfizer and Moderna vaccines were more than 90% effective. But the numbers aren’t exactly comparable. And all three shots prevent hospitalization and death.